Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Micro Cap & Branchenriese: Heute rein? - Partnerschaft entfacht Übernahmefantasien!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14QUY | ISIN: GB00BVG7F061 | Ticker-Symbol: 7IG
Tradegate
21.01.25
15:30 Uhr
16,600 Euro
-0,100
-0,60 %
Branche
Unterhaltung
Aktienmarkt
Sonstige
1-Jahres-Chart
INTERNATIONAL GAME TECHNOLOGY PLC Chart 1 Jahr
5-Tage-Chart
INTERNATIONAL GAME TECHNOLOGY PLC 5-Tage-Chart
RealtimeGeldBriefZeit
16,40016,70020:19
16,50016,60020:13
PR Newswire
70 Leser
Artikel bewerten:
(0)

International Game Technology PLC: IGT Wins 10-Year Contract with Loterie Nationale to Deliver World-Class Lottery and iLottery Solutions in Luxembourg

Finanznachrichten News

LONDON, Jan. 21, 2025 /PRNewswire/ -- International Game Technology PLC ("IGT") (NYSE: IGT) announced today that its subsidiary, IGT Global Services Limited, signed a 10-year contract with the national lottery of Luxembourg, Loterie Nationale. Under the terms of the agreement, IGT will deploy its high-performing, player-centric OMNIA solution, including its cloud-based iLottery system and remote game server ("RGS"), an upgrade to the Lottery's central gaming system, and new point-of-sale terminals and peripherals. This contract was awarded following a European public procurement procedure and is expected to run through 2036.

"IGT has been a trusted partner to Loterie Nationale for more than 20 years, supporting retail growth and digital evolution," said Léon Losch, Loterie Nationale Director. "Upgrading our lottery and iLottery solutions with IGT's advanced technology can pave the way for our continued sales growth, provide our players with best-in-class experiences and position us to continue our support of good causes."

"Over the course of IGT's longstanding partnership with Loterie Nationale, we've helped support the growth of its point-of-sale footprint, addition of self-service terminals in retail locations and launch of iLottery in the region," said Jay Gendron, IGT Chief Operating Officer Global Lottery. "We look forward to continuing that momentum through our future-forward technology portfolio that gives Loterie Nationale access to top-performing IGT games, improved analytics, advanced responsible gaming tools and increased scalability."

OMNIA is IGT's integrated lottery solution, bringing together its leading retail and digital lottery solutions, ensuring centralized and consistent data and innovative solutions to modernize the retail playing experience. Developed to drive lottery innovation and profitability, OMNIA will provide Loterie Nationale with a full suite of intuitive, user-friendly applications, tools, and reporting capabilities. As part of the agreement, IGT will also deliver newly updated Retailer Pro terminals, providing cutting-edge technology for high-volume retailers, along with GameTouch and GameTouch Draw S2 self-service lottery vending machines.

A natively integrated OMNIA component, IGT's cloud-based iLottery system offers dynamic scalability, reduced time to market for system enhancements, and comprehensive responsible gaming features. IGT's RGS platform allows access to IGT's vast portfolio of digital instant games and content, spanning a variety of player-favorite themes, play styles, omnichannel games, popular licensed content, and award-winning progressive jackpot games.

As the global lottery market leader, IGT is the primary technology provider to 26 of the 46 lotteries in the U.S., eight of the world's largest 10 lotteries and 16 of the world's top 25 lotteries. For more information, visit IGT.com and follow us on LinkedIn.

About IGT
IGT (NYSE:IGT) is a global leader in gaming. We deliver entertaining and responsible gaming experiences for players across all channels and regulated segments, from Lotteries and Gaming Machines to Sports Betting and Digital. Leveraging a wealth of compelling content, substantial investment in innovation, player insights, operational expertise, and leading-edge technology, our solutions deliver unrivaled gaming experiences that engage players and drive growth. We have a well-established local presence and relationships with governments and regulators in more than 100 jurisdictions around the world, and create value by adhering to the highest standards of service, integrity, and responsibility. IGT has approximately 11,000 employees. For more information, please visit www.igt.com.

Cautionary Statement Regarding Forward-Looking Statements
This news release may contain forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning International Game Technology PLC and its consolidated subsidiaries (the "Company") and other matters. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, products and services, customer relationships, results of operations, or financial condition, or otherwise, based on current beliefs of the management of the Company as well as assumptions made by, and information currently available to, such management. Forward-looking statements may be accompanied by words such as "aim," "anticipate," "believe," "plan," "could," "would," "should," "shall," "continue," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "will," "possible," "potential," "predict," "project" or the negative or other variations of them. These forward-looking statements speak only as of the date on which such statements are made and are subject to various risks and uncertainties, many of which are outside the Company's control. Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may differ materially from those predicted in the forward-looking statements and from past results, performance, or achievements. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include (but are not limited to) the factors and risks described in the Company's annual report on Form 20-F for the financial year ended December 31, 2023 and other documents led from time to time with the SEC, which are available on the SEC's website at www.sec.gov and on the investor relations section of the Company's website at www.IGT.com. Except as required under applicable law, the Company does not assume any obligation to update these forward-looking statements. You should carefully consider these factors and other risks and uncertainties that affect the Company's business. All forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement. All subsequent written or oral forward-looking statements attributable to International Game Technology PLC, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement.

Contact:
Phil O'Shaughnessy, Global Communications, toll free in U.S./ Canada +1 (844) IGT-7452; outside U.S./ Canada +1 (401) 392-7452
Matteo Selva, Italian media inquiries, +39 366 6803635
James Hurley, Investor Relations, +1 (401) 392-7190

© 2025 IGT

The trademarks and/or service marks used herein are either trademarks or registered trademarks of IGT, its affiliates or its licensors.

SOURCE International Game Technology PLC

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.